Foundational Work at NIH and Today’s Transformative Treatments
For the 100,000 people in the United States and 8 million people worldwide with sickle cell disease (SCD), there are now two big reasons to be optimistic: Two FDA-approved gene therapies for SCD have been added to the armament of potentially curative therapies. We report on how NIH has been at the forefront of SCD research for decades and is advancing today's curative therapies.
Read more